Porphyrins, Quantitative, Random Urine

9 biomarkers Sample: Urine Peer-reviewed

Biomarkers in this category

9 biomarkers · optimal ranges shown

What is the ALA/Creatinine Ratio? The ALA/Creatinine Ratio measures the amount of delta-aminolevulinic acid (ALA) in your urine, standardized against creatinine to account for urine concentration differences. ALA is a key intermediate in the heme synthesis pathway, which your body uses to make heme—a crucial component of hemoglobin in red blood cells. This ratio is especially useful in diagnosing acute porphyrias and other disorders of heme metabolism. By adjusting for creatinine, the test gives a more accurate view of ALA excretion regardless of how diluted or concentrated the urine is. Why is this test ordered? This test is often ordered when a healthcare provider suspects a porphyria, particularly: Acute Intermittent Porphyria (AIP) Hereditary Coproporphyria (HCP) Variegate Porphyria (VP) Lead poisoning Tyrosinemia Type I (in infants/children) You may be asked to do this test if you're experiencing unexplained, recurring symptoms, such as: Severe abdominal pain Nausea or vomiting Muscle weakness Anxiety, confusion, or hallucinations Seizures Reddish or dark urine (especially during acute episodes) What does an elevated ALA/Creatinine Ratio mean? An elevated ALA/Creatinine Ratio typically indicates increased production and urinary excretion of delta-aminolevulinic acid. This often points to disrupted heme biosynthesis, and is most commonly seen in: 1. Acute Hepatic Porphyrias When an enzyme deficiency prevents the body from completing heme synthesis, intermediates like ALA build up and spill into the urine. ALA and porphobilinogen (PBG) are both elevated during acute attacks. 2. Lead Poisoning Lead inhibits multiple enzymes in the heme synthesis pathway, especially ALA dehydratase, causing a marked rise in urinary ALA without a proportional rise in PBG. This pattern helps distinguish lead toxicity from porphyria. 3. Tyrosinemia Type I In infants, especially those with failure to thrive, liver dysfunction, or neurological symptoms, high ALA levels may point to this rare metabolic disorder. What should you do if your ALA/Creatinine Ratio is elevated? If your ALA/Creatinine Ratio is high: Your doctor may order additional confirmatory tests, including: Porphobilinogen (PBG)/Creatinine Ratio Total urine porphyrins Blood lead levels Genetic testing for porphyrias If porphyria is suspected, it's critical to collect urine during an acute attack, as levels may normalize between episodes. Avoid known triggers of porphyria attacks, such as: Fasting or crash diets Alcohol Hormonal shifts (e.g., menstruation) Certain prescription drugs (barbiturates, sulfa drugs, some anticonvulsants) If lead poisoning is suspected, urgent chelation therapy and environmental investigation may be required. How is this different from just measuring ALA? Urine concentration can vary widely depending on hydration. Measuring ALA alone can be misleading—dilute urine might show a falsely low level. By expressing it as a ratio to creatinine, clinicians get a clearer, more reliable picture of your body’s ALA excretion, allowing for better diagnostic accuracy. Bottom Line An elevated ALA/Creatinine Ratio in random urine is a strong biochemical clue for acute porphyria, lead poisoning, or other heme-related metabolic disorders. If you're experiencing recurrent, unexplained symptoms—especially involving the nervous system or abdomen—this test may provide critical answers. Follow-up testing and early treatment can prevent serious complications.

The "PBG/Creatinine Ratio" marker found on a Porphobilinogen, Quantitative, Random Urine panel by LabCorp is a crucial test for evaluating the presence and concentration of porphobilinogen (PBG) in urine in relation to creatinine levels. This test is significant for diagnosing and monitoring conditions related to abnormal porphyrin metabolism, such as acute intermittent porphyria, among others. Porphyria refers to a group of disorders that result from a buildup of natural chemicals that produce porphyrin in your body. Porphobilinogen is a precursor in the biosynthesis of heme, the iron-containing prosthetic group found in hemoglobin. Normally, the body regulates the production of porphobilinogen and other intermediates in the heme production pathway. However, genetic conditions can disrupt this balance, leading to the accumulation of toxic precursors like PBG. Measuring the PBG/Creatinine Ratio is particularly useful because it helps normalize the PBG level to the amount of creatinine in the urine, providing a more accurate assessment of the body's porphyrin metabolism than measuring PBG levels alone. Creatinine is a waste product produced by muscles from the breakdown of a compound called creatine. Creatinine levels in the urine can vary based on muscle mass, hydration status, and kidney function. By comparing PBG levels to creatinine levels, healthcare providers can obtain a clearer picture of the body's chemical balance and more accurately diagnose and manage porphyria and related metabolic conditions.